ARIAD PHARMACEUTICALS INC Proceeds from Convertible Debt
ARIAD PHARMACEUTICALS INC reported Proceeds from Convertible Debt of $200.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2016-02-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2016-02-29
- ARIAD PHARMACEUTICALS INC proceeds from convertible debt for the quarter ending 2014-12-31 was $7.08M.
- ARIAD PHARMACEUTICALS INC proceeds from convertible debt for the quarter ending 2014-09-30 was -$1.08M.
- ARIAD PHARMACEUTICALS INC proceeds from convertible debt for fiscal 2014 was $200.00M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month | Proceeds from Convertible Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $7.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $6.00M derived: sum of 2 quarters · filed 2016-02-29 | $200.00M 10-K · filed 2016-02-29 | $192.92M 10-K · filed 2015-03-02 | |
| 2014-09-30 | -$1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $192.92M 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | $194.00M 10-Q · filed 2015-08-07 |